Search

Author/Creator Kaufman, Keith D.

1. A randomized clinical trial evaluating the efficacy and safety of the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy. (3rd October 2017)

Authors:
Shankar, R. Ravi; Inzucchi, Silvio E.; Scarabello, Victoria; Gantz, Ira; Kaufman, Keith D.; Lai, Eseng; Ceesay, Paulette; Suryawanshi, Shailaja; Engel, Samuel S.
Journal:
Current medical research and opinion
Issue:
Volume 33:Number 10(2017)
Page Start:
1853
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A randomized clinical trial evaluating the safety and efficacy of sitagliptin added to the combination of sulfonylurea and metformin in patients with type 2 diabetes mellitus and inadequate glycemic control: 一项评估联合使用磺脲与二甲双胍治疗后血糖仍然控制不佳的2型糖尿病患者加用西格列汀治疗后的安全性与有效性的随机临床试验. (3rd February 2016)

Authors:
Moses, Robert G.; Round, Elizabeth; Shentu, Yue; Golm, Gregory T.; O'neill, Edward A.; Gantz, Ira; Engel, Samuel S.; Kaufman, Keith D.; Goldstein, Barry J.
Journal:
Journal of diabetes
Issue:
Volume 8:Number 5(2016:Sep.)
Page Start:
701
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes. Issue 2 (22nd December 2021)

Authors:
Shankar, R. Ravi; Zeitler, Philip; Deeb, Asma; Jalaludin, Muhammad Yazid; Garcia, Raymundo; Newfield, Ron S.; Samoilova, Yulia; Rosario, Carmen A.; Shehadeh, Naim; Saha, Chandan K.; Zhang, Yilong; Zilli, Martina; Scherer, Lynn W.; Lam, Raymond L. H.; Golm, Gregory T.; Engel, Samuel S.; Kaufman, K...
Journal:
Pediatric diabetes
Issue:
Volume 23:Issue 2(2022)
Page Start:
173
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A randomized clinical trial of the efficacy and safety of sitagliptin compared with dapagliflozin in patients with type 2 diabetes mellitus and mild renal insufficiency: The CompoSIT‐R study. Issue 12 (16th August 2018)

Authors:
Scott, Russell; Morgan, Jerry; Zimmer, Zachary; Lam, Raymond L. H.; O'Neill, Edward A.; Kaufman, Keith D.; Engel, Samuel S.; Raji, Annaswamy
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 20:Issue 12(2018)
Page Start:
2876
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. A randomized clinical trial of the safety and efficacy of sitagliptin in patients with type 2 diabetes mellitus inadequately controlled by acarbose alone. (3rd April 2017)

Authors:
Wang, Weiqing; Ning, Guang; Ma, Jianhua; Liu, Xiaomin; Zheng, Shaoxiong; Wu, Fan; Xu, Lei; O'Neill, Edward A.; Fujita, Kenji P.; Engel, Samuel S.; Kaufman, Keith D.; Shankar, R. Ravi
Journal:
Current medical research and opinion
Issue:
Volume 33:Number 4(2017)
Page Start:
693
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. A randomized, double-blind trial evaluating the efficacy and safety of monotherapy with the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in people with type 2 diabetes. (April 2018)

Authors:
Home, Philip; Shankar, R. Ravi; Gantz, Ira; Iredale, Carol; O'Neill, Edward A.; Jain, Lokesh; Pong, Annpey; Suryawanshi, Shailaja; Engel, Samuel S.; Kaufman, Keith D.; Lai, Eseng
Journal:
Diabetes research and clinical practice
Issue:
Volume 138(2018)
Page Start:
253
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. A randomized, double-blind, non-inferiority trial evaluating the efficacy and safety of omarigliptin, a once-weekly DPP-4 inhibitor, or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy. (3rd October 2017)

Authors:
Handelsman, Yehuda; Lauring, Brett; Gantz, Ira; Iredale, Carol; O'Neill, Edward A.; Wei, Ziwen; Suryawanshi, Shailaja; Kaufman, Keith D.; Engel, Samuel S.; Lai, Eseng
Journal:
Current medical research and opinion
Issue:
Volume 33:Number 10(2017)
Page Start:
1861
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. A randomized, placebo‐ and sitagliptin‐controlled trial of the safety and efficacy of omarigliptin, a once‐weekly dipeptidyl peptidase‐4 inhibitor, in Japanese patients with type 2 diabetes. Issue 11 (6th July 2017)

Authors:
Gantz, Ira; Okamoto, Taro; Ito, Yuka; Okuyama, Kotoba; O'Neill, Edward A.; Kaufman, Keith D.; Engel, Samuel S.; Lai, Eseng
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 19:Issue 11(2017)
Page Start:
1602
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. A randomized, placebo‐controlled trial to assess the efficacy and safety of sitagliptin in Japanese patients with type 2 diabetes and inadequate glycaemic control on ipragliflozin. Issue 6 (28th February 2021)

Authors:
Seino, Yutaka; Kaku, Kohei; Kadowaki, Takashi; Okamoto, Taro; Sato, Asako; Shirakawa, Masayoshi; O'Neill, Edward A.; Engel, Samuel S.; Kaufman, Keith D.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 23:Issue 6(2021)
Page Start:
1342
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Double‐blind, randomized clinical trial assessing the efficacy and safety of early initiation of sitagliptin during metformin uptitration in the treatment of patients with type 2 diabetes: The CompoSIT‐M study. Issue 5 (17th February 2019)

Authors:
Frias, Juan P.; Zimmer, Zachary; Lam, Raymond L.H.; Amorin, Guillermo; Ntabadde, Catherine; Iredale, Carol; O'Neill, Edward A.; Engel, Samuel S.; Kaufman, Keith D.; Makimura, Hideo; Crutchlow, Michael F.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 21:Issue 5(2019)
Page Start:
1128
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗